Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
4
×
cancer immunotherapy
4
×
deals
detroit blog main
detroit top stories
indiana blog main
4
×
indiana top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
boston top stories
crispr
eli lilly
ipo
takeda pharmaceutical
abbvie
aduro biotech
alexion pharmaceuticals
What
bio
roundup
companies
drug
new
pharmaceutical
price
typically
acquisitions
alzheimer’s
announced
approval
bails
biogen’s
biopharmaceutical
brand
bridgebio
capital
car
ceo
collabs
convo
covid
daniel
deal
develop
different
drugs
earlier
emerges
fail
failures
firm
gene
gilead
gilead’s
grab
headlines
help
ichnos
Language
unset
Current search:
novartis
×
national
×
" cancer immunotherapy "
×
" indiana blog main "
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More